Dalbavancin
- 1 January 2008
- journal article
- review article
- Published by Springer Science and Business Media LLC in Drugs
- Vol. 68 (5), 639-648
- https://doi.org/10.2165/00003495-200868050-00006
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Pharmacokinetics of dalbavancin in plasma and skin blister fluidJournal of Antimicrobial Chemotherapy, 2007
- Spectrum and potency of dalbavancin tested against 3322 Gram-positive cocci isolated in the United States Surveillance Program (2004)Diagnostic Microbiology and Infectious Disease, 2006
- Guidelines for the prophylaxis and treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in the UKJournal of Antimicrobial Chemotherapy, 2006
- Antimicrobial Spectrum and Potency of Dalbavancin Tested Against Clinical Isolates from Europe and North America (2003): Initial Results from an International Surveillance ProtocolJournal of Chemotherapy, 2005
- Pharmacokinetics and excretion of dalbavancin in the ratJournal of Antimicrobial Chemotherapy, 2005
- Derivatives of a Vancomycin-Resistant Staphylococcus aureus Strain Isolated at Hershey Medical CenterAntimicrobial Agents and Chemotherapy, 2004
- Efficacy of Dalbavancin against Methicillin-Resistant Staphylococcus aureus in the Rat Granuloma Pouch Infection ModelAntimicrobial Agents and Chemotherapy, 2004
- Activities of Dalbavancin In Vitro and in a Rabbit Model of Experimental Endocarditis Due to Staphylococcus aureus with or without Reduced Susceptibility to Vancomycin and TeicoplaninAntimicrobial Agents and Chemotherapy, 2004
- Once-Weekly Dalbavancin versus Standard-of-Care Antimicrobial Regimens for Treatment of Skin and Soft-Tissue InfectionsClinical Infectious Diseases, 2003
- A Practical Guide to the Treatment of Complicated Skin and Soft Tissue InfectionsDrugs, 2003